82 related articles for article (PubMed ID: 24863889)
1. Nuchal translucency thickness in the prediction of unbalanced translocations.
Arigita M; Grande M; Mula R; Borobio V; Sanchez A; Soler A; Borrell A
Prenat Diagn; 2014 Oct; 34(10):982-5. PubMed ID: 24863889
[TBL] [Abstract][Full Text] [Related]
2. Nuchal translucency thickness in fetuses with chromosomal translocation at 11-12 weeks of gestation.
Cheng PJ; Chang SD; Shaw SW; Soong YK
Obstet Gynecol; 2005 May; 105(5 Pt 1):1058-62. PubMed ID: 15863545
[TBL] [Abstract][Full Text] [Related]
3. Nuchal translucency thickness and outcome in chromosome translocation diagnosed in the first trimester.
Sepulveda W; Be C; Youlton R; Carstens E; Reyes M
Prenat Diagn; 2001 Sep; 21(9):726-8. PubMed ID: 11559907
[TBL] [Abstract][Full Text] [Related]
4. First-trimester combined screening is effective for the detection of unbalanced chromosomal translocations at 11 to 12 weeks of gestation.
Huang S; Chang C; Cheng P; Hsiao C; Soong Y; Duan T
Reprod Sci; 2014 May; 21(5):594-600. PubMed ID: 24177714
[TBL] [Abstract][Full Text] [Related]
5. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
6. Use of fetal nuchal translucency in the first trimester to predict single-gene disorders.
Arigita M; Borrell A; Mula R; Sanchez A; Milà M; Gratacos E
Prenat Diagn; 2011 Dec; 31(12):1164-8. PubMed ID: 22025256
[TBL] [Abstract][Full Text] [Related]
7. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
Lam YH; Tang MH; Lee CP; Tse HY
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
[TBL] [Abstract][Full Text] [Related]
8. Nuchal translucency in twins according to mode of assisted conception and chorionicity.
Maymon R; Cuckle H; Svirsky R; Sheena L; Melcer Y; Rozen H; Ben-Ami I
Ultrasound Obstet Gynecol; 2014 Jul; 44(1):38-43. PubMed ID: 24339187
[TBL] [Abstract][Full Text] [Related]
9. Is high fetal nuchal translucency associated with submicroscopic chromosomal abnormalities on array CGH?
Huang J; Poon LC; Akolekar R; Choy KW; Leung TY; Nicolaides KH
Ultrasound Obstet Gynecol; 2014 Jun; 43(6):620-4. PubMed ID: 24719361
[TBL] [Abstract][Full Text] [Related]
10. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
11. Prospective validation of first-trimester combined screening for trisomy 21.
Kagan KO; Etchegaray A; Zhou Y; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Jul; 34(1):14-8. PubMed ID: 19526452
[TBL] [Abstract][Full Text] [Related]
12. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
13. Nuchal translucency thickness in euploid fetuses: is two millimeters too risky?
Fink M; Sheiner E; Sheizaf B; Hershkovitz R; Bashiri A; Mazor M; Wiznitzer A
Am J Perinatol; 2009 Apr; 26(4):303-7. PubMed ID: 19031359
[TBL] [Abstract][Full Text] [Related]
14. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population.
Westin M; Saltvedt S; Almström H; Grunewald C; Valentin L
Ultrasound Obstet Gynecol; 2007 Feb; 29(2):150-8. PubMed ID: 17211897
[TBL] [Abstract][Full Text] [Related]
15. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z
Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277
[TBL] [Abstract][Full Text] [Related]
16. Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta-analysis.
Sotiriadis A; Papatheodorou S; Eleftheriades M; Makrydimas G
Ultrasound Obstet Gynecol; 2013 Oct; 42(4):383-9. PubMed ID: 23606595
[TBL] [Abstract][Full Text] [Related]
17. Male gender as a favorable prognostic factor in pregnancies with enlarged nuchal translucency.
Timmerman E; Pajkrt E; Bilardo CM
Ultrasound Obstet Gynecol; 2009 Oct; 34(4):373-8. PubMed ID: 19618399
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diagnosis of β-thalassemia: nuchal translucency in affected fetuses.
Di Fraja D; Sarno L; Migliucci A; Acampora E; Napolitano R; Maruotti GM; Martinelli P
Minerva Ginecol; 2011 Dec; 63(6):491-4. PubMed ID: 22036753
[TBL] [Abstract][Full Text] [Related]
19. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.
Spencer K; Cowans NJ; Molina F; Kagan KO; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Feb; 31(2):147-52. PubMed ID: 17992705
[TBL] [Abstract][Full Text] [Related]
20. Nuchal translucency distributions for different chromosomal anomalies in a large unselected population cohort.
Christiansen M; Ekelund CK; Petersen OB; Hyett J; Eastwood N; Ball S; Tabor A; Vogel I
Prenat Diagn; 2016 Jan; 36(1):49-55. PubMed ID: 26505467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
